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ABSTRACT 
Objectives: Among challenges in health research is translating interventions from controlled 
experimental settings to clinical and community settings where chronic disease is managed 
daily. Pragmatic trials offer a method for testing interventions in real-world settings, but are 
seldom used in osteoarthritis research. We evaluate the literature on pragmatic trials in 
osteoarthritis research up to August 2016 in order to identify strengths and weaknesses in the 
design and reporting of these trials.  
Methods: We used established guidelines to assess the degree to which 61 osteoarthritis 
studies complied with pragmatic trial design and reporting. We assessed design according to 
the pragmatic-explanatory continuum indicator summary (PRECIS), and reporting according to 
the pragmatic trials extension of the CONSORT (CONsolidated Standards of Reporting Trials) 
guidelines. 
Results: None of the pragmatic trials met all 11 criteria evaluated, most of the trials met 
between 5 and 8 of the criteria. Criteria most often unmet pertained to practitioner expertise 
(by requiring specialists), and criteria most often met pertained to primary outcome analysis (by 
using intention-to-treat analysis).  
Conclusion: Our results suggest a lack of highly pragmatic trials in osteoarthritis research. We 
identify this as a point of opportunity to improve research translation, since optimizing the 
design and reporting of pragmatic trials can facilitate implementation of evidence-based 
interventions for osteoarthritis care.  
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INTRODUCTION 
The prevalence of osteoarthritis is expected to rise with population aging [1]. There is no cure 
for osteoarthritis, but there are strategies that can reduce progression and mitigate symptoms 
[2, 3]. The challenge lies in effective implementation of these interventions, particularly since 
there are demonstrated practice gaps in the delivery of osteoarthritis care [4]. Implementation 
research aims to reduce the gap between what is known to be clinically effective and what is 
actually delivered in clinical care [5]. Allen et al. provide an overview of the design and conduct 
of implementation trials of interventions for osteoarthritis [6]. The authors describe conceptual 
frameworks (e.g. knowledge-to-action), study designs (e.g. pragmatic trials), and evaluations 
(both process and formative) for implementation trials.  
 
Pragmatic trials are particularly useful in implementation research, since they are designed to 
determine the generalizability of interventions to routine practice [6]. Whereas explanatory 
trials are used to test the efficacy of interventions in controlled settings, pragmatic trials are 
used to demonstrate the effectiveness of interventions in real-world settings [7, 8]. In theory, 
pragmatic trials test interventions that are evidence-based with flexibiity for application across 
multiple settings with large and heterogeneous populations, looking at stakeholder-related 
outcomes over longer periods of time [9, 10]. In practice, this may not always be the case.  
 
The objective of this study is to evaluate the degree to which existing pragmatic trials in 
osteoarthritis research comply with guidelines for the design and reporting of pragmatic trials 
[11, 12]. We identify strengths and weaknesses of pragmatic trials in osteoarthritis research, 
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and suggest ways in which pragmatic trial guidelines can be applied to osteoarthritis research 
to achieve highly pragmatic trials. By optimizing pragmatic trial methodology in osteoarthritis 
research, we can facilitate implementation of evidence-based interventions in routine practice, 
and reduce care gaps.  
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METHODS 
We searched PubMed and Web of Science using the terms “pragmatic AND trial AND 
osteoarthritis [All Fields]” to identify publications prior to August 2016. Our search identified 63 
citations from PubMed and 93 citations from Web of Science, with 96 unique citations 
combined (Supplementary Figure 1). We included articles that explicitly stated that the study 
was “pragmatic” in the title (36%), abstract (59%), or methods/discussion (5%). We excluded 
articles that were not reports of primary research, were not available in full-text or English, and 
were not related to osteoarthritis. We excluded reports of trial results when reports of trial 
protocol for the same study were already included. For each study, we determined whether the 
intervention was clinician-based (oral drug, injections, acupuncture, surgery, or clinical 
pathways) or patient-based (diet, exercise, self-management programs, devices, topical 
therapies), and which joints were targeted (Supplementary Table 1). 
 
We used the pragmatic-explanatory continuum indicator summary (PRECIS) [11] and the 
pragmatic trials extension of the CONSORT (CONsolidated Standards of Reporting Trials) [12] 
guidelines to determine the parameters of an ideal pragmatic trial in osteoarthritis research 
[13, 14]. Guidelines for optimal pragmatic trial design (PRECIS) and reporting (CONSORT) were 
consistent, with an additional guideline for reporting ‘Blinding’ in the CONSORT extension. We 
combined these guidelines into 11 criteria (Table 1) to evaluate each of the 61 studies reporting 
a pragmatic trial in osteoarthritis research. Determinations were made for each criterion using 
a simple binary system to indicate whether the study met pragmatic criteria (yes = 1) or not (no 
= 0), where a maximum score of 11 could be assigned per study (Supplementary Table 2). After 
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being trained to code [15], two independent raters (KL and KW) evaluated each study. Inter-
rater agreement of coding for a random sample of studies (N=30) was determined to be 78%. A 
third reviewer (SAA) evaluated any discrepancies in coding (an average of 3 criteria per study).  
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RESULTS 
None of the 61 pragmatic trials we evaluated met all 11 criteria described in Table 1. Most of 
the trials, for both clinician- and patient-based interventions, met 5 to 8 of the criteria 
(Supplementary Figure 2). Few trials were at either extreme, meeting 9 or more criteria, or 4 or 
less criteria (Supplementary Figure 2). Of note, 5% of studies met 9 or more criteria, suggesting 
that it is possible, but rare, to have highly pragmatic trials in osteoarthritis research.  
 
The criteria that most studies failed to meet were practitioner expertise for both experimental 
and comparison interventions. This requires the intervention be applied by practitioners 
ordinarily involved with the care of patients [11]. For osteoarthritis patients, this typically 
includes general practitioners, pharmacists, family, and friends. Only 10% of studies met this 
criterion for the experimental intervention and only 34% for the comparison intervention 
(Table 2). The majority of studies required additional training of practitioners delivering the 
intervention, or included experts that would require special referral in many health care 
systems (e.g. physiotherapists, orthopaedic surgeons).  
 
Only 41% of studies met pragmatic trial guidelines for participant eligibility criteria (Table 2). As 
described by Thorpe et al., trials with minimal inclusion and exclusion criteria are considered 
pragmatic [11]. The majority of trials we evaluated imposed specific participant eligibility 
criteria relating to the severity or type of osteoarthritis (inclusion criteria), and the presence of 
co-morbidities (exclusion criteria), and seldom explained why. For example, 61% of studies 
recruited participants with knee osteoarthritis (16% knee and hip, 5% hip, 5% did not specify a 
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joint, 8% generalized osteoarthritis, 3% hand, 2% shoulder), and many studies excluded 
participants who had undergone joint replacement or other surgical interventions. These design 
decisions may be appropriate for trials examining interventions for specific populations, but do 
not capture the osteoarthritis population with multiple morbidities due to advanced age, and 
with persistent symptoms in the same or additional joints after surgery.  
 
We found 48% of studies met criteria for flexibility of the comparison intervention (Table 2), 
where pragmatic trials use the existing standard of care as the comparison intervention [11]. 
This number may be inflated since many studies did not report the standard of care, so we 
assumed no changes were made. Many studies did change the standard of care, for example by 
offering the comparison group information pamphlets. Lack of reporting was also evident for 
blinding procedures. Traditional single- or double-blinding may not always be possible for 
pragmatic trials [10], but only 43% of studies provided an explanation for the blinding decisions 
(Table 2).  
 
Pragmatic trials avoid monitoring participant compliance with the intervention [11]; we found 
54% of the studies met this criterion (Table 2). Several studies required participants to keep 
track of a behaviour using diaries or logs over extended periods of time. While compliance 
measures may help researchers explain effect sizes, they may also introduce an observer effect. 
Truly pragmatic trials accept non-compliance as a reality [13]. This relates to flexibility of the 
experimental intervention, for which 51% of studies met the criterion (Table 2). Pragmatic trials 
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have interventions that are not closely monitored, that are flexible in delivery, and that 
accommodate variation across settings [13].  
 
Strengths of pragmatic trials in osteoarthritis research include the choice of primary trial 
outcome, where 82% of studies used outcomes that were minimally invasive and clinically 
meaningful to participants (e.g. pain, quality of life, function), and analysis of primary outcome, 
where 87% of studies used intention-to-treat analysis. We found 79% of studies did not monitor 
practitioner adherence to the study protocol, although this number may reflect a common 
practice to refrain from monitoring practitioners rather than a research effort to comply with 
pragmatic trial guidelines. We found 77% of studies met the criterion for minimizing follow-up 
intensity, although we allowed for up to 2 follow-ups, and considered any follow-up by phone 
or mail to be pragmatic (Table 2).  
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DISCUSSION 
In osteoarthritis research, studies that self-identify as pragmatic trials fail to meet many criteria 
for the design and reporting of pragmatic trials. While the PRECIS tool [11] is not intended as a 
method for classifying trials, it is useful for evaluating the degree to which pragmatic trials meet 
design recommendations [13, 15]. Our results show that most trials have both pragmatic and 
explanatory elements, supporting the idea of a pragmatic-explanatory continuum in trial design 
[11, 13].  
 
Ideally, pragmatic trials should maximize external validity, and this requires moving away from 
the controlled conditions of traditional explanatory trials. In the ‘real-world’, populations are 
heterogeneous with different stages of osteoarthritis, practitioners apply protocols variably, 
and patients may not fully comply with interventions, particularly since osteoarthritis is 
deprioritized in clinical settings [4]. Yet for scientific rigor, trials must have some 
inclusion/exclusion criteria, practitioners must follow protocol to some degree, an appropriate 
comparison group is needed, and some type of follow-up is required to measure change in 
outcomes. As a result, there is considerable tension for some pragmatic trials criteria, between 
minimizing bias and maximizing generalizability [10]. How these tensions are reconciled will 
depend on the research question and parameters of individual studies [7].  
 
Going forward, improved reporting of design decisions can reveal whether trials are more 
pragmatic, more explanatory, or potentially negligent in a particular domain of trial design. We 
did not evaluate overall quality of the studies included, but only what was reported, making it 
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difficult to distinguish shortcomings in design versus reporting. Although 75% of the studies 
included were published after the CONSORT extension for pragmatic trials was available in 2008 
[12], it appears that there are still deficiencies in reporting of pragmatic trials.  
 
To clarify what may constitute a pragmatic trial in osteoarthritis research, we identified 
common design decisions that are consistent with guidelines (Table 1). The list in Table 1 is not 
exhaustive and was formulated based on the pragmatic trials we evaluated, of which 41% were 
clinician-based interventions and 59% were patient-based interventions. Existing guidelines for 
pragmatic trials had to be flexibly applied for trials with clinician-based interventions to qualify 
as pragmatic. We found eligibility criteria were more specific, experimental and comparison 
interventions were less flexible, practitioner adherence to protocol was stricter, and follow-up 
intensity was more frequent – out of necessity for surgical and pharmacologic interventions. 
Therefore, if the trial design captured as closely as possible the way in which the intervention 
would ultimately be delivered in usual clinical care, we considered it pragmatic. 
 
We excluded articles that were not related to osteoarthritis or declared as pragmatic trials, 
making our search specific, but not necessarily sensitive. Other studies may have incorporated 
elements of pragmatic trial design without declaring the trial type as pragmatic, or may have 
tested interventions for joint pain without declaring an osteoarthritis diagnosis. This may have 
resulted in under-counting of pragmatic trials in osteoarthritis in our literature search. Other 
articles may have inappropriately declared the trial type as pragmatic, causing our results to 
reflect poor design and reporting and an overall lack of highly pragmatic trials. The underlying 
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issue may be a lack of clarity and consensus in the field about what constitutes a pragmatic trial 
[7].  
 
It remains unclear whether trials are not sufficiently pragmatic, or whether existing pragmatic 
trial guidelines are not appropriate. Ultimately, pragmatic trials test implementation of 
interventions in the real-world, and what constitutes ‘real-world’ will differ depending on the 
intervention type (in-home for many lifestyle interventions, hospital-based for surgical 
interventions), the end-users (patients, clinicians, policy-makers), and the social, political, and 
economic contexts in which the intervention will ultimately be delivered [16]. It is difficult to 
prove whether having more trials that are more pragmatic will improve implementation of 
evidence-based interventions [17]. Certainly without pragmatic trials and implementation 
research, practitioners may lack trial evidence that is amenable to their clinical context, and this 
may hinder their ability to operationalize clinical practice guidelines. 
 
In conclusion, there is a lack of highly pragmatic trials in osteoarthritis research, as defined by 
current guidelines for the design [11] and reporting [12] of pragmatic trials. Understanding 
existing pragmatic trial guidelines and how they can be applied to osteoarthritis research may 
improve use of this method in implementation research. Further efforts are needed to achieve 
a common understanding among researchers about what constitutes a pragmatic trial.    
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KEY MESSAGES 
• Only 61 self-identified pragmatic trials on osteoarthritis were published prior to August 
2016.  
• Existing pragmatic trials in osteoarthritis research show variable compliance with 
established guidelines.  
• Most pragmatic trials met guidelines for ‘Analysis of primary outcome’, but not 
‘Practitioner expertise’. 
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TABLE/FIGURE LEGENDS 
 
Table 1. Summary of PRECIS (11) and CONSORT (12) guidelines, showing their overlap and 
application to pragmatic trials in osteoarthritis research.   
 
Table 2. Evaluation of pragmatic trials in osteoarthritis research.  Number (and percentage) of 
studies that met each criteria, separated by clinician- or patient-based intervention, and 
combined.  
 
Supplementary Figure 1. Flowchart of literature search strategy.  
 
Supplementary Figure 2. Distribution of summed scores for each pragmatic trial evaluated 
(N=61), with a maximum possible score of 11. Clinician-based intervention (black bars) = oral 
drug, injections, acupuncture, surgery, or clinical pathways. Patient-based intervention (grey 
bars) = diet, exercise, self-management programs, devices, topical therapies. 
 
Supplementary Table 1. Summary of included studies. 
 
Supplementary Table 2. Detailed evaluation of pragmatic trials in osteoarthritis research.   
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ABSTRACT 
Objectives: Among challenges in health research is translating interventions from controlled 
experimental settings to clinical and community settings where chronic disease is managed 
daily. Pragmatic trials offer a method for testing interventions in real-world settings, but are 
seldom used in osteoarthritis research. Objective: We evaluate the literature on pragmatic 
trials in osteoarthritis research up to August 2016 in order to identify strengths and weaknesses 
in the design and reporting of these trials.  
Methods: We used established guidelines to assess the degree to which 61 osteoarthritis 
studies complied with pragmatic trial design [pragmatic-explanatory continuum indicator 
summary (PRECIS)] and reporting. [pragmatic trials extension of the CONSORT (CONsolidated 
Standards of Reporting Trials) guidelines]. We assessed design according to the pragmatic-
explanatory continuum indicator summary (PRECIS), and reporting according to the pragmatic 
trials extension of the CONSORT (CONsolidated Standards of Reporting Trials) guidelines. 
Results: None of the pragmatic trials met all 11 criteria evaluated, most of the trials met 
between 5 and 8 of the criteria. Criteria most often unmet pertained to practitioner expertise 
(by requiring specialists), and criteria most often met pertained to primary outcome analysis (by 
using intention-to-treat analysis).  
Conclusion: Our results suggest a lack of highly pragmatic trials in osteoarthritis research. We 
identify this as a point of opportunity to improve research translation, since ; optimizing the 
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design and reporting of pragmatic trials can facilitate implementation of evidence-based 
interventions for osteoarthritis care.  
 
KEY WORDS 
pragmatic trials, osteoarthritis, PRECIS, CONSORT, implementation 
 
 
 
 
INTRODUCTION 
The prevalence of osteoarthritis is expected to rise with population aging [1]. There is no cure 
for osteoarthritis, but there are strategies that can reduce progression and mitigate symptoms 
[2, 3]. The challenge lies in effective implementation of these interventions, particularly since 
there are demonstrated practice gaps in the delivery of osteoarthritis care [4]. Implementation 
research aims to reduce the gap between what is known to be clinically effective and what is 
actually delivered in clinical care [5]. Allen et al. provide an overview of the design and conduct 
of implementation trials of interventions for osteoarthritis [6]. The authors describe conceptual 
frameworks (e.g. knowledge-to-action), study designs (e.g. pragmatic trials), and evaluations 
(both process and formative) for implementation trials.  
 
Pragmatic trials are particularly useful in implementation research, since they are designed to 
determine the generalizability of interventions to routine practice [6]. Whereas explanatory 
trials are used to test the efficacy of interventions in controlled settings, pragmatic trials are 
used to demonstrate the effectiveness of interventions in real-world settings [7, 8]. In theory, 
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pragmatic trials test interventions that are evidence-based with apply interventions flexibility 
for application across y in multiple settings with large and heterogeneous populations, and 
looking at stakeholder-related outcomes over longer periods of time [9, 10]. In practice, this 
may not always be the case.  
 
The objective of this study is to evaluate the degree to which existing pragmatic trials in 
osteoarthritis research comply with guidelines for the design and reporting of pragmatic trials 
[11, 12]. We identify strengths and weaknesses of pragmatic trials in osteoarthritis research, 
and suggest ways in which pragmatic trial guidelines can be applied to osteoarthritis research 
to achieve highly pragmatic trials. By optimizing pragmatic trial methodology in osteoarthritis 
research, we can facilitate implementation of evidence-based interventions in routine practice, 
and reduce care gaps.  
 
METHODS 
We searched PubMed and Web of Science using the terms “pragmatic AND trial AND 
osteoarthritis [All Fields]” to identify publications prior to August 2016. Our search identified 63 
citations from PubMed and 93 citations from Web of Science, with 96 unique citations 
combined (Supplementary Figure 1). We included articles that explicitly stated that the study 
was “pragmatic” in the title (36%), abstract (59%), or methods/discussion (5%). We excluded 
articles that were not reports of primary research, were not available in full-text or English, and 
were not related to osteoarthritis. We excluded reports of trial results when reports of trial 
protocol for the same study were already included. For each study, we determined whether the 
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intervention was medical clinician-based (administered by a health professional: oral drug, 
injections, acupuncture, surgery, or clinical pathways) or lifestyle patient-based (administered 
by the individual: diet, exercise, self-management programs, devices, topical therapies), and 
which joints were targeted (Supplementary Table 1). 
 
We used the pragmatic-explanatory continuum indicator summary (PRECIS) [11] and the 
pragmatic trials extension of the CONSORT (CONsolidated Standards of Reporting Trials) [12] 
guidelines to determine the parameters of an ideal pragmatic trial in osteoarthritis research 
[13, 14]. Guidelines for optimal pragmatic trial design (PRECIS) and reporting (CONSORT) were 
consistent, with an additional guideline for reporting ‘Blinding’ in the CONSORT extension. We 
combined these guidelines into 11 criteria (Table 1) to evaluate each of the 61 studies reporting 
a pragmatic trial in osteoarthritis research. Determinations were made for each criterion using 
a simple binary system to indicate whether the study met pragmatic criteria (yes = 1) or not (no 
= 0), where a maximum score of 11 could be assigned per study (Supplementary Table 2). After 
being trained to code [15], two independent raters (KL and KW) evaluated each study. Inter-
rater agreement of coding for a random sample of studies (N=30) was determined to be 78%. A 
third reviewer (SAA) evaluated any discrepancies in coding (an average of 3 criteria per study).  
 
RESULTS 
None of the 61 pragmatic trials we evaluated met all 11 criteria described in Table 1. Most of 
the trials, for both medical clinician- and patient-based lifestyle interventions, met 5 to 8 of the 
criteria (Figure 1ASupplementary Figure 2). Few trials were at either extreme, meeting 9 or 
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more criteria, or 4 or less criteria (Figure 1ASupplementary Figure 2). Of note, 5% of studies 
met 9 or more criteria, suggesting that it is possible, but rare, to have highly pragmatic trials in 
osteoarthritis research.  
 
The criteria that most studies failed to meet were practitioner expertise for both experimental 
and comparison interventions. This requires the intervention be applied by practitioners 
ordinarily involved with the care of patients [11]. For osteoarthritis patients, this typically 
includes general practitioners, pharmacists, family, and friends. Only 10% of studies met this 
criterion for the experimental intervention and only 34% for the comparison intervention 
(Figure 1BTable 2). The majority of studies required additional training of practitioners 
delivering the intervention, or included experts that would require special referral in many 
health care systems (e.g. physiotherapists, orthopaedic surgeons).  
 
Only 41% of studies met pragmatic trial guidelines for participant eligibility criteria (Figure 
1BTable 2). As described by Thorpe et al., trials with minimal inclusion and exclusion criteria are 
considered pragmatic [11]. The majority of trials we evaluated imposed specific participant 
eligibility criteria relating to the severity or type of osteoarthritis (inclusion criteria), and the 
presence of co-morbidities (exclusion criteria), and seldom explained why. For example, 61% of 
studies recruited participants with knee osteoarthritis (16% knee and hip, 5% hip, 5% did not 
specify a joint, 8% generalized osteoarthritis, 3% hand, 2% shoulder), and many studies 
excluded participants who had undergone joint replacement or other surgical interventions. 
These design decisions may be appropriate for trials examining interventions for specific 
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populations, but do not capture the osteoarthritis population with multiple morbidities due to 
advanced age, and with persistent symptoms in the same or additional joints after surgery.  
 
We found 48% of studies met criteria for flexibility of the comparison intervention (Figure 
1BTable 2), where pragmatic trials use the existing standard of care as the comparison 
intervention [11]. This number may be inflated since many studies did not report the standard 
of care, so we assumed no changes were made. Many studies did change the standard of care, 
for example by offering the comparison group information pamphlets. Lack of reporting was 
also evident for blinding procedures. Traditional single- or double-blinding may not always be 
possible for pragmatic trials [10], but only 43% of studies provided an explanation for the 
blinding decisions (Figure 1BTable 2).  
 
Pragmatic trials avoid monitoring participant compliance with the intervention [11]; we found 
54% of the studies met this criterion (Figure 1BTable 2). Several studies required participants to 
keep track of a behaviour using diaries or logs over extended periods of time. While compliance 
measures may help researchers explain effect sizes, they may also introduce an observer effect. 
Truly pragmatic trials accept non-compliance as a reality [13]. This relates to flexibility of the 
experimental intervention, for which 51% of studies met the criterion (Figure 1BTable 2). 
Pragmatic trials have interventions that are not closely monitored, that are flexible in delivery, 
and that accommodate variation across settings [13].  
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Strengths of pragmatic trials in osteoarthritis research include the choice of primary trial 
outcome, where 82% of studies used outcomes that were minimally invasive and clinically 
meaningful to participants (e.g. pain, quality of life, function), and analysis of primary outcome, 
where 87% of studies used intention-to-treat analysis. We found 79% of studies did not monitor 
practitioner adherence to the study protocol, although this number may reflect a common 
practice to refrain from monitoring practitioners rather than a research effort to comply with 
pragmatic trial guidelines. We found 77% of studies met the criterion for minimizing follow-up 
intensity, although we allowed for up to 2 follow-ups, and considered any follow-up by phone 
or mail to be pragmatic (Figure 1BTable 2).  
 
DISCUSSION 
In osteoarthritis research, studies that self-identify as pragmatic trials fail to meet many criteria 
for the design and reporting of pragmatic trials. While the PRECIS tool [11] is not intended as a 
method for classifying trials, it is useful for evaluating the degree to which pragmatic trials meet 
design recommendations [13, 15]. Our results show that most trials have both pragmatic and 
explanatory elements, supporting the idea of a pragmatic-explanatory continuum in trial design 
[11, 13].  
 
Ideally, pragmatic trials should maximize external validity, and this requires moving away from 
the controlled conditions of traditional explanatory trials. In the ‘real-world’, populations are 
heterogeneous with different stages of osteoarthritis, practitioners apply protocols variably, 
and patients may not fully comply with interventions, particularly since osteoarthritis is 
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deprioritized in clinical settings [4]. Yet for scientific rigor, trials must have some 
inclusion/exclusion criteria, practitioners must follow protocol to some degree, an appropriate 
comparison group is needed, and some type of follow-up is required to measure change in 
outcomes. As a result, there is considerable tension for some pragmatic trials criteria, between 
minimizing bias and maximizing generalizability [10]. How these tensions are reconciled will 
depend on the research question and parameters of individual studies [7].  
 
Going forward, improved reporting of design decisions can reveal whether trials are more 
pragmatic, more explanatory, or potentially negligent in a particular domain of trial design. In 
this study, We did not evaluate overall quality of the studies included, butwe could only 
evaluate what was reported, making it sometimes difficult to distinguish shortcomings in design 
versus reporting. Although 75% of the studies included were published after the CONSORT 
extension for pragmatic trials was available in 2008 [12], it appears that there are still 
deficiencies in reporting of pragmatic trials.  
 
To clarify what may constitute a pragmatic trial in osteoarthritis research, we identified 
common design decisions that are consistent with guidelines (Table 1). The list in Table 1 is not 
exhaustive and was formulated based on the pragmatic trials we evaluated, of which 41% were 
medical clinician-based interventions and 59% were lifestyle patient-based interventions. 
Existing guidelines for pragmatic trials had to be flexibly applied for trials with medical clinician-
based interventions to qualify as pragmatic. We found eligibility criteria were more specific, 
experimental and comparison interventions were less flexible, practitioner adherence to 
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protocol was stricter, and follow-up intensity was more frequent – out of necessity for surgical 
and pharmacologic interventions. Therefore, if the trial design captured as closely as possible 
the way in which the intervention would ultimately be delivered in usual medical clinical care, 
we considered it pragmatic. 
 
We excluded articles that were not related to osteoarthritis or declared as pragmatic trials, 
making our search specific, but not necessarily sensitive. , since oOther studies may have 
incorporated elements of pragmatic trial design without declaring the trial type as pragmatic, or 
may have tested interventions for joint pain without declaring an osteoarthritis diagnosis. This 
may have resulted in under-counting of pragmatic trials in osteoarthritis in our literature 
search. Other articles may have inappropriately declared the trial type as pragmatic, causing 
our results to reflect poor design and reporting and an overall lack of highly pragmatic trials. 
The underlying issue may be a lack of clarity and consensus in the field about what constitutes a 
pragmatic trial [7].  
 
It remains unclear whether trials are not sufficiently pragmatic, or whether existing pragmatic 
trial guidelines are not appropriate. Ultimately, pragmatic trials test implementation of 
interventions in the real-world, and what constitutes ‘real-world’ will differ depending on the 
intervention type (in-home for many lifestyle interventions, hospital-based for surgical 
interventions), the end-users (patients, clinicians, policy-makers), and the social, political, and 
economic contexts in which the intervention will ultimately be delivered [16]. It is difficult to 
prove whether having more trials that are more pragmatic will improve implementation of 
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evidence-based interventions [17]. Certainly without pragmatic trials and implementation 
research, practitioners may lack trial evidence that is amenable to their clinical context, and this 
may hinder their ability to operationalize clinical practice guidelines. 
 
In conclusion, there is a lack of highly pragmatic trials in osteoarthritis research, as defined by 
current guidelines for the design [11] and reporting [12] of pragmatic trials. Understanding 
existing pragmatic trial guidelines and how they can be applied to osteoarthritis research may 
improve use of this method in implementation research. Further efforts are needed to achieve 
a common understanding among researchers about what constitutes a pragmatic trial.    
 
 
 
 
 
KEY MESSAGES 
• Pragmatic trials facilitate implementation of health research, but are seldom used in 
osteoarthritis research.  
• Only 61 self-identified pragmatic trials on osteoarthritis were published prior to August 
2016.  
• Existing pragmatic trials in osteoarthritis research show variable compliance with 
established guidelines.  
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• Most pragmatic trials met guidelines for ‘Analysis of primary outcome’, but not 
‘Practitioner expertise’. 
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TABLE/FIGURE LEGENDS 
 
Table 1. Summary of PRECIS (110) and CONSORT (121) guidelines, showing their overlap and 
application to pragmatic trials in osteoarthritis research.   
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Figure Table 21. Evaluation of pragmatic trials in osteoarthritis research. A) Distribution of 
summed scores for each pragmatic trial evaluated (N=61), with a maximum possible score of 
11. Medical = oral drug, injections, acupuncture, surgery, or clinical pathways. Lifestyle = diet, 
exercise, self-management programs, devices, topical therapies. B) Number (and percentage) of 
studies that met each criteria, separated by medical clinician- or patient-based lifestyle 
intervention, and combined.  
 
Supplementary Figure 1. Flowchart of literature search strategy.  
Supplementary Figure 2. Distribution of summed scores for each pragmatic trial evaluated 
(N=61), with a maximum possible score of 11. Clinician-based intervention (black bars) = oral 
drug, injections, acupuncture, surgery, or clinical pathways. Patient-based intervention (grey 
bars) = diet, exercise, self-management programs, devices, topical therapies. 
Supplementary Table 1. Summary of included studies. 
Supplementary Table 2. Evaluation of included studies using 11 criteria for pragmatic trials. 
 
Page 31 of 50 Rheumatology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Table 1. 
 
 
Design (PRECIS) Reporting (CONSORT) A pragmatic trial in osteoarthritis research: 
1 Participant eligibility criteria Participants 
Captures the target population (e.g. does 
not exclude people with co-morbidities) 
 
Experimental intervention Interventions 
 
2 
 
  Flexibility Generalizability 
Implements an intervention that can be 
delivered after the study concludes 
3 
 
  Practitioner expertise 
 
Relies on a general practitioner or other 
typical OA care provider  
 
Comparison intervention  Background 
 
4 
 
  Flexibility 
 
Describes current standard of care, does not 
alter it (e.g. by providing pamphlets) 
5 
 
  Practitioner expertise 
 
Relies on a general practitioner or other 
typical OA care provider  
6 Follow-up intensity Outcomes 
Measures outcomes infrequently, and at 
least 6 months following the intervention 
7 Primary trial outcome Sample Size 
Uses minimally invasive outcomes that are 
meaningful to the participant (e.g. function) 
8 Participant compliance  
 
Does not track participant compliance (e.g. 
with self-reports in diaries/logs) 
9 Practitioner adherence  
 
Does not monitor general practitioner/OA 
care provider adherence to study protocol  
10 Analysis of primary outcome Participant Flow 
Includes all participants in an intention-to-
treat analysis of the primary outcome 
11 
  
Blinding  
Provides an explanation for blinding 
decisions 
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Criteria 
Clinician-
based 
intervention 
(N=25) 
Patient-
based 
intervention 
(N=36) 
Combined 
(N=61) 
Participant eligibility criteria 12 (48%) 13 (36%) 25 (41%) 
Experimental intervention 
   
 
Flexibility 13 (52%) 18 (50%) 31 (51%) 
 
Practitioner expertise 5 (20%) 1 (3%) 6 (10%) 
Comparison intervention  
   
 
Flexibility 12 (48%) 17 (47%) 29 (48%) 
 
Practitioner expertise 9 (36%) 12 (33%) 21 (34%) 
Follow-up intensity 17 (68%) 30 (83%) 47 (77%) 
Primary trial outcome 19 (76%) 31 (86%) 50 (82%) 
Participant compliance  14 (56%) 19 (53%) 33 (54%) 
Practitioner adherence  21 (84%) 27 (75%) 48 (79%) 
Analysis of primary outcome 19 (76%) 34 (94%) 53 (87%) 
Blinding 8 (32%) 18 (50%) 26 (43%) 
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B 
 
 
    
Criteria 
Clinician-
based 
intervention 
Medical 
(N=25) 
Patient-
based 
intervention 
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Supplementary Table 1. Summary of included studies        
       
Citation Study question Intervention Protocol 
paper 
Pragmatic 
score  
Bilkman T, Rienstra W, Raaij T, Hagen A, Dijkstra B, 
Zijlstra W, et al. Duloxetine in OsteoArthritis (DOA) 
study: study protocol of a pragmatic open-label 
randomised controlled trial assessing the effect of 
preoperative pain treatment on postoperative outcome 
after total hip or knee arthroplasty. BMJ Open. 
2016;6(3). 
What are the effects of 
preoperative pain treatment on 
postoperative outcomes using 
duloxetine for hip or knee OA? 
drug protocol 7 
Callahan LF, Callahan LF, Cleveland RJ, Altpeter M, 
Hackney B. Evaluation of Tai Chi Program Effectiveness 
for People with Arthritis in the Community: A 
Randomized Controlled Trial. Journal of aging and 
physical activity. 2016;24(1):101. 
What is the effectiveness of the 
Arthritis Foundation Tai Chi 
Program for community 
participants with arthritis? 
exercise  8 
Deyle G, Gill N, Rhon D, Allen C, Allison S, Hando B, et al. 
A multicentre randomised, 1-year comparative 
effectiveness, parallel-group trial protocol of a physical 
therapy approach compared to corticosteroid injections. 
BMJ Open. 2016;6(3). 
What is the effectiveness of 
physical therapy compared to 
corticosteroid injections alone 
for knee OA? 
physiotherapy protocol 4 
Yu SP, Williams M, Eyles JP, Chen JS, Makovey J, Hunter 
DJ. Effectiveness of knee bracing in osteoarthritis: 
pragmatic trial in a multidisciplinary clinic. International 
Journal of Rheumatic Diseases. 2016;19(3):279-286. 
What is the effectiveness of 
bracing treatment for 
tibiofemoral osteoarthritis ( OA 
) and patellofemoral OA in 
patients with knee OA? 
bracing  6 
Beard D, Rees J, Rombach I, Cooper C. Trials: The CSAW 
Study (Can Shoulder Arthroscopy Work?) - a placebo-
controlled surgical intervention trial assessing the clinical 
and cost effectiveness of arthroscopic subacromial 
decompression for shoulder pain: study protocol for a 
randomised controlled trial. Trials. 2015;16(5):210. 
What is the efficacy and cost-
effectiveness of ASAD 
(Arthroscopic subacromial 
decompression) in patients with 
subacromial pain? 
surgery protocol 5 
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Cuperus N, Hoogeboom T, Kersten C, et al. Randomized 
trial of the effectiveness of a non-pharmacological 
multidisciplinary face-to-face treatment program on 
daily function compared to a telephone-based treatment 
program in patients with generalized osteoarthritis. 
Osteoarthritis and Cartilage 2015. 23:1267–1275. 
How effective is non-
pharmacological 
multidisciplinary face-to-face 
group-based treatment program 
versus a telephone-delivered 
treatment program on daily 
function for patients with 
generalized OA? 
self-management  6 
Eymard F, Charles-Nelson A, Katsahian S, Chevalier X, 
Bercovy M. “Forgotten knee” after total knee 
replacement: A pragmatic study from a single-centre 
cohort. Joint Bone Spine. 2015;82(3):177-181. 
What is the prevalence of 
“forgotten knee” (FK) after TKR 
in a prospective pragmatic 
cohort, with comparison to 
conventional scores? 
surgery  4 
Kingsbury SR, Tharmanathan P, Arden NK, Batley M, 
Birrell F, Cocks K, et al. Pain reduction with oral 
methotrexate in knee osteoarthritis, a pragmatic phase 
iii trial of treatment effectiveness (PROMOTE): study 
protocol for a randomized controlled trial. Trials. 
2015;16:77. 
How effective is oral 
methotraxate for reducing 
synovitis (and pain) patients 
with knee OA? 
methotrexate protocol 5 
Moonaz SH, Bingham CO, Wissow L, Bartlett SJ. Yoga in 
Sedentary Adults with Arthritis: Effects of a Randomized 
Controlled Pragmatic Trial. The Journal of Rheumatology. 
2015;42(7):1194–1202. 
Can integral-based hatha yoga 
improve fitnesss, mood, stress 
and quality of life for people 
with knee RA or OA? 
yoga  5 
Teirlinck CH, Luijsterburg PA, Dekker J, Bohnen AM, 
Verhaar JA, Koopmanschap MA, et al. Effectiveness of 
exercise therapy added to general practitioner care in 
patients with hip osteoarthritis: a pragmatic randomized 
controlled trial. Osteoarthritis and Cartilage. 
2015;24(1):82-90. 
How effective is exercise at 
improving function and pain for 
individuals with hip OA? 
exercise therapy  7 
Bevers K, Zweers MC, Vriezekolk JE, Bijlsma JW, den 
Broeder AA. Are ultrasonographic signs of inflammation 
predictors for response to intra-articular glucocorticoids 
in knee osteoarthritis? Clinical and Experimental 
Rheumatology. 2014;32(6):930–934. 
What is the predictive value of 
ultrasound characteristics for 
the effect of intra-articular 
glucocorticoids in knee OA? 
glucocorticoid 
injection 
 6 
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Broderick JE, Keefe FJ, Bruckenthal P, Junghaenel DU, 
Schneider S, Schwartz JE, et al. Nurse practitioners can 
effectively deliver pain coping skills training to 
osteoarthritis patients with chronic pain: A randomized, 
controlled trial. Pain. 2014;155(9):1743–1754. 
How effectiveness are 10 
education sessions about pain 
management faciliated by 
health nurses for patients with 
OA of knee or hip? 
coping  7 
Dobson F, Hinman RS, French S, Rini C, Keefe F, Nelligan 
R, et al. Internet-mediated physiotherapy and pain 
coping skills training for people with persistent knee pain 
(IMPACT – knee pain): a randomised controlled trial 
protocol. BMC Musculoskelet Disorders. 2014;15:279. 
Is an internet-delivered 
intervention that combines 
PCST and physiotherapist-
guided exercise more effective 
than online educational material 
in people with persistent knee 
pain? 
coping/physio/exercise protocol 6 
Foster NE, Healey EL, Holden MA, Nicholls E, Whitehurst 
DG, Jowett S, et al. A multicentre, pragmatic, parallel 
group, randomised controlled trial to compare the 
clinical and cost-effectiveness of three physiotherapy-led 
exercise interventions for knee osteoarthritis in older 
adults: the BEEP trial protocol (ISRCTN: 93634563). BMC 
Musculoskelet Disorders. 2014;15:254. 
How effective are individuallly 
tailored exercise programs 
versus usual physiptherapy care 
for adherence? 
physio/exercise protocol 6 
Hermann M, Nilsen T, Eriksen CS, Slatkowsky-
Christensen B, Haugen IK, Kjeken I. Effects of a soft 
prefabricated thumb orthosis in carpometacarpal 
osteoarthritis. Scandinavian Journal of Occupational 
Therapy. 2014;21:31-39. 
How does the use of a hand 
orthosis versus no orthosis 
affect pain? 
orthosis  7 
Janke E, Fritz M, Hopkins C, Haltzman B, Sautter J, 
Ramirez M. A randomized clinical trial of an integrated 
behavioral self-management intervention 
Simultaneously Targeting Obesity and Pain: the STOP 
trial. BMC Public Health. 2014;14:621. 
What is the effectiveness of an 
integrated treatment (STOP) for 
weight loss and reduction in 
pain intensity? 
behavioral self-
management 
intervention 
protocol 3 
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Kjeken I, Berdal G, Bo I, Dager T, Dingsor A, Hagfors J, et 
al. Evaluation of a structured goal planning and tailored 
follow-up programme in rehabilitation for patients with 
rheumatic diseases: protocol for a pragmatic, stepped-
wedge cluster randomized trial. BMC Musculoskeletal 
Disorders. 2014;15:153. 
What is the clinical and cost-
effectiveness of a structured 
goal planning and tailored 
follow-up rehabilitation 
programme for patients with 
rheumatic diseases? 
goal planning and 
tailored follow-up 
programme 
protocol 5 
Martins F, Kaster T, Schützler L, Witt CM. Factors 
Influencing Further Acupuncture Usage and a more 
positive outcome in patients with osteoarthritis of the 
knee and the hip: a 3-year follow-up of a randomized 
pragmatic trial. The Clinical Journal of Pain. 
2014;30(11):953–959. 
How does immediate versus 
delayed acupuncture affect the 
long term outcomes for people 
with OA? 
acupuncture  6 
Rabago D, Patterson JJ, Mundt M, Zgierska A, Fortney L, 
Grettie J, et al. Dextrose and Morrhuate Sodium 
Injections (Prolotherapy) for Knee Osteoarthritis: A 
prospective open-label trial. Journal of Alternative and 
Complementary Medicine. 2014;20(5):383–391. 
Do scheduled hypertonic 
dextrose and morrhuate sodium 
injections improved knee pain, 
function and stiffness for knee 
osteoarthritis? 
dextrose & morrhuate 
sodium 
 6 
Beard D, Price A, Cook J, Fitzpatrick R, Carr A, Campbell 
M, et al. Total or Partial Knee Arthroplasty Trial - 
TOPKAT: study protocol for a randomised controlled 
trial. Trials. 2013;14:292. 
What is the clinical and cost 
effectiveness of total knee 
replacements versus 
unicompartmental 
replacements for patients with 
medial compartment 
osteoarthritis? 
total vs. 
unicompartment 
replacement 
protocol 4 
Kim EJ, Lim CY, Lee EY, Lee SD, Kim KS. Comparing the 
effects of individualized, standard, sham and no 
acupuncture in the treatment of knee osteoarthritis: a 
multicenter randomized controlled trial. Trials. 
2013;14:129. 
How efficient is meridian-based 
syndrome differentiation and 
Sa-am for reducing pain in knee 
OA? 
acupunture protocol 6 
Lee S, Kim KH, Kim TH, Kim JE, Kim JH, Kang JW, et al. 
Moxibustion for treating knee osteoarthritis: study 
protocol of a multicentre randomised controlled trial. 
BMC Complementary and Alternative Medicine. 
2013;13:59. 
Determined if moxibustin 
(orietal therapy where herbs are 
burned on certain areas of skin) 
could reduce pain and improve 
activity for knee OA. 
moxibustion + 
acupuncture 
protocol 6 
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Salisbury C, Montgomery AA, Hollinghurst S, Hopper C. 
Effectiveness of PhysioDirect telephone assessment and 
advice services for patients with musculoskeletal 
problems: pragmatic randomised controlled trial. British 
Medical Journal. 2013;346:f43. 
What is the clinical 
effectiveness, effect on waiting 
times, and patient acceptability 
of PhysioDirect services in 
patients with musculoskeletal 
problems? 
telephone assessment 
and advice service 
 3 
Uehleke B, Müller J, Stange R, Kelber O, Melzer J. Willow 
bark extract STW 33-I in the long-term treatment of 
outpatients with rheumatic pain mainly osteoarthritis or 
back pain. Phytomedicine. 2013;20(11):980–984. 
Does Willow bark extract reduce 
long term pain in individuals 
with OA or back pain? 
STW 33-I  8 
Adams J, Bridle C, Dosanjh S, Heine P, Lamb SE, Lord J, et 
al. Strengthening and stretching for rheumatoid arthritis 
of the hand (SARAH): design of a randomised controlled 
trial of a hand and upper limb exercise intervention. 
BMC Musculoskeletal Disorders. 2012;13:230. 
What is the clinical and cost 
effectiveness of an optimized 
exercise programme for hand 
and upper limb OA? 
exercise program  5 
Bennell KL, Egerton T, Bills C, Gale J, Kolt GS, Bunker SJ, 
et al. Addition of telephone coaching to a 
physiotherapist-delivered physical activity program in 
people with knee osteoarthritis: a randomised controlled 
trial protocol. BMC Musculoskeletal Disorders. 
2012;13:246. 
Does adding telephone coaching 
to a physiotherapist-delivered 
physical activity improve clinical 
and cost effectiveness of the 
intervention for people with 
knee OA? 
telephone-coaching protocol 5 
Dakin H, Gray A, Fitzpatrick R, MacLennan G, Murray D. 
Rationing of total knee replacement: a cost-effectiveness 
analysis on a large trial data set. BMJ Open. 
2012;2:e000332. 
What is the cost-effectiveness 
of total knee replacements 
versus no knee replacement 
patients with OA? 
TKA cost effectiveness  9 
Gooch K, Marshall DA, Faris PD, Khong H, Wasylak T, 
Pearce T, et al. Comparative effectiveness of alternative 
clinical pathways for primary hip and knee joint 
replacement patients: a pragmatic randomized, 
controlled trial. Osteoarthritis and Cartilage. 
2012;20(10):1086–1094. 
How effective is the new clinical 
pathway (featuring central 
intake clinics, dedicated 
inpatient resources, care 
guidelines and efficiency 
benchmarks) vs the standard of 
care for THR or Total k nee 
replacement for OA? 
clinical pathway  8 
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Hinman RS, McCrory P, Pirotta M, Relf I, Crossley KM, 
Reddy P, et al. Efficacy of acupuncture for chronic knee 
pain: protocol for a randomised controlled trial using a 
Zelen design. BMC Complementary and Alternative 
Medicine. 2012;12:161. 
What is the cost-effectiveness 
and efficiency for needle and 
laser apcupuncture for relieving 
chronic knee pain? 
acupuncture protocol 7 
Hurley MV, Walsh NE, Mitchell H, Nicholas J, Patel A. 
Long-term outcomes and costs of an integrated 
rehabilitation program for chronic knee pain: a 
pragmatic, cluster randomized, controlled trial. Arthritis 
Care & Research. 2012;64(2):238–247. 
What is the long-term (up to 30 
months) clinical and cost 
effectiveness of a rehabilitation 
program combining self-
management and exercise? 
self-management  6 
Rathleff M, Roos E, Olesen J, Rasmussen S. Early 
intervention for adolescents with Patellofemoral Pain 
Syndrome - a pragmatic cluster randomised controlled 
trial. BMC Musculoskeletal Disorders. 2012;13:9. 
What is the short- and long-
term effectiveness of patient 
education compared with 
patient education and 
physiotherapy for 
patellofemoral pain syndrome 
in adolescents? 
patient education and 
physiotherapy 
protocol 6 
Breeman S, Campbell M, Dakin H, Fiddian N, Fitzpatrick 
R, Grant A, et al. Patellar resurfacing in total knee 
replacement: five-year clinical and economic results of a 
large randomized controlled trial. The Journal of Bone 
and Joint Surgery-American Volume. 2011;93(16):1473–
1481. 
What are the advantages and 
disadvantages of patellar 
resurfacing and selective 
resurfacing? 
surgical effectiveness  8 
Christensen P, Bliddal H, Riecke BF, Leeds AR, Astrup A, 
Christensen R. Comparison of a low-energy diet and a 
very low-energy diet in sedentary obese individuals: a 
pragmatic randomized controlled trial. Clinical Obesity. 
2011;1(1):31–40. 
Does a very low-energy formula 
diet cause greater weight loss 
than a formula 810 kcal d-1LED 
in older sedentary individuals? 
diet  1 
Juhakoski R, Tenhonen S, Malmivaara A, Kiviniemi V, 
Anttonen T, Arokoski JP. A pragmatic randomized 
controlled study of the effectiveness and cost 
consequences of exercise therapy in hip osteoarthritis. 
Clinical Rehabilitation. 2011;25(4):370–383. 
What is the short- and long-
term effectiveness of exercise 
training in relation to pain, 
function and direct costs to 
health care systems attributable 
to hip OA? 
exercise  6 
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Minns Lowe CJ, Wilson MS, Sackley CM, Barker KL. Blind 
outcome assessment: the development and use of 
procedures to maintain and describe blinding in a 
pragmatic physiotherapy rehabilitation trial. Clinical 
Rehabilitation. 2011;25(3):264–274. 
What is the effectiveness of a 
postdischarge physiotherapy 
intervention in improving 
patient function after total knee 
arthroplasty for OA? 
blinding (physio)  7 
Cadmus L, Patrick MB, Maciejewski ML, Topolski T, Belza 
B, Patrick DL. Community-Based Aquatic Exercise and 
Quality of Life in Persons with Osteoarthritis. Medicine & 
Science in Sports & Exercise. 2010;42(1):8–15. 
What is the effectiveness of a 
community-based aquatic 
exercise program to improve 
quality of life among persons 
with osteoarthritis? 
aquatic exercise  8 
Moe RH, Uhlig T, Kjeken I, Hagen KB, Kvien TK, Grotle M. 
Multidisciplinary and multifaceted outpatient 
management of patients with osteoarthritis: protocol for 
a randomised, controlled trial. BMC Musculoskeletal 
Disorders. 2010;11:253. 
What are the effects of a 
multidisciplinary outpatient 
clinic with a brief group-based 
educational programme, versus 
a traditional individual 
outpatient clinic for patients 
with hip, knee, hand or 
generalized OA? 
self-management protocol 7 
Riecke BF, Christensen R, Christensen P, Leeds AR, 
Boesen M, Lohmander LS, et al. Comparing two low-
energy diets for the treatment of knee osteoarthritis 
symptoms in obese patients: a pragmatic randomized 
clinical trial. Osteoarthritis and Cartilage. 
2010;18(6):746–754. 
What is the symptom response 
for patients assigned a very low 
energy diet versus a low energy 
diet, for patients who are obese 
and have knee OA? 
diet  1 
Gooch, K.L., Smith, D., Wasylak, T., Faris, P.D., Marshall, 
D.A., Khong, H., Hibbert, J.E., Parker, R.D., Zernicke, R.F., 
Beaupre, L., Pearce, T., Johnston, D.W.C. and Frank, C.B. 
The Alberta hip and knee replacement project: A model 
for health technology assessment based on comparative 
effectiveness of clinical pathways. International Journal 
of Technology Assessment in Health Care. 
2009;25(2):113-123. 
Can the Alberta Hip and Knee 
Replacement Project be used as 
a model as a model for health 
technology assessment based 
on comparative effectiveness of 
alternative clinical pathways? 
study effectiveness of 
clinical pathway 
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Harmer AR, Naylor JM, Crosbie J, Russell T. Land-based 
versus water-based rehabilitation following total knee 
replacement: A randomized, single-blind trial. Arthritis 
Care & Research. 2009;61(2):184-191. 
What are the outcomes for 
land-based and water-based 
exercise programs after total 
knee replacement (TKR)? 
exercise program  8 
Jenkinson CM, Doherty M, Avery AJ, Read A, Taylor MA, 
Sach TH, et al. Effects of dietary intervention and 
quadriceps strengthening exercises on pain and function 
in overweight people with knee pain: randomised 
controlled trial. The BMJ. 2009;339:b3170. 
How do dietary intervention 
plus quadriceps strengthening 
exercises; dietary intervention 
alone; quadriceps strengthening 
exercises alone; advice leaflet 
only (control group) effect knee 
pain in obese patients? 
diet + exercise  7 
Jessep SA, Walsh NE, Ratcliffe J, Hurley MV. Long-term 
clinical benefits and costs of an integrated rehabilitation 
programme compared with outpatient physiotherapy for 
chronic knee pain. Physiotherapy. 2009;95(2):94–102. 
What is the feasibility of 
ESCAPE-knee pain, clinical 
effectiveness and costs versus 
outpatient physiotherapy? 
physio/exercise  6 
Lansdown H, Howard K, Brealey S, MacPherson H. 
Acupuncture for pain and osteoarthritis of the knee: a 
pilot study for an open parallel-arm randomised 
controlled trial. BMC Musculoskeletal Disorders. 
2009;10:130. 
How effective is acupuncture 
versus usual care to reduce 
knee OA pain? 
acupuncture  7 
Lin CC, March L, Crosbie J, Crawford R, Graves S, Naylor J, 
et al. Maximum recovery after knee replacement – the 
MARKER study rationale and protocol. BMC 
Musculoskeletal Disorders. 2009;10:69. 
What is the clinical and cost 
effectiveness of an initial home 
exercise programme followed 
by higher intensity outpatient 
exercise classes after knee 
replacement? 
exercise program protocol 6 
Rahmann AE, Brauer SG, Nitz JC. A specific inpatient 
aquatic physiotherapy program improves strength after 
total hip or knee replacement surgery: a randomized 
controlled trial. Archives of Physical Medicine and 
Rehabilitation. 2009;90(5):745–755. 
What is the effect of inpatient 
aquatic physiotherapy versus 
regular physiotherapy to 
recover of strength, function, 
and gait speed after total hip or 
knee replacement surgery due 
to OA? 
aquatic physio  6 
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Ravaud P, Flipo R-M, Boutron I, Roy C, Mahmoudi A, 
Giraudeau B et al. ARTIST (osteoarthritis intervention 
standardized) study of standardised consultation versus 
usual care for patients with osteoarthritis of the knee in 
primary care in France: pragmatic randomised controlled 
trial. British Medical Journal. 2009; 338:b421. 
What is the impact of 
standardized consultations on 
patients with osteoarthritis of 
the knee? 
standardised 
consultations 
5 6 
Itoh K, Hirota S, Katsumi Y, Ochi H, Kitakoji H. Trigger 
point acupuncture for treatment of knee osteoarthritis - 
a preliminary RCT for a pragmatic trial. Acupuncture in 
Medicine. 2008;26(1):17-26. 
What is the effect of trigger 
point acupuncture on pain and 
quality-of-life in knee 
osteoarthritis patients, 
compared with acupuncture at 
standard points, and sham 
acupuncture? 
accupuncture  4 
Brealey SD, (Direct Access to Magnetic Resonance 
Imaging: Assessment for Suspect Knees) Trial Team. 
Influence of magnetic resonance imaging of the knee on 
GPs’ decisions: a randomised trial. The British Journal of 
General Practice. 2007;57(541):622-629. 
What is the effect of early 
access to MRI, compared with 
referral to an orthopaedic 
specialist for knee problems? 
MRI  4 
Brinks A, van Rijn R, Bohnen A, Slee G, Verhaar J, Koes B, 
et al. Effect of corticosteroid injection for trochanter 
pain syndrome: design of a randomised clinical trial in 
general practice. BMC Musculoskeletal Disorders. 
2007;8:95. 
What is the efficacy of local 
corticosteroid injections in the 
trochanter syndrome in the 
general practice? 
corticosteroid injection protocol 6 
Hurley MV, Walsh NE, Mitchell HL, Pimm TJ, Patel A, 
Williamson E, et al. Clinical effectiveness of a 
rehabilitation program integrating exercise, 
self-management, and active coping strategies for 
chronic knee pain: A cluster randomized trial. Arthritis 
Care & Research. 2007;57(7):1211-1219. 
Is a rehabilitation program 
integrating exercise, 
self-management, and active 
coping strategies effective for 
OA? 
rehabilitation program  9 
Page 46 of 50Rheumatology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Rosemann T, Joos S, Laux G, Gensichen J, Szecsenyi J. 
Case management of arthritis patients in primary care: A 
cluster-randomized controlled trial1. Arthritis Care & 
Research. 2007;57(8):1390-1397. 
Does providing information on 
arthritis self-management 
through general practitioners 
(GPs) increase quality of life and 
does additional case 
management provided by 
practice nurses shows better 
results? 
providing information 
and case-management 
 8 
Hay, E, Foster N, Thomas E, Peat G, Phelan M, Yates H et 
al. Effectiveness of community physiotherapy and 
enhanced pharmacy review for knee pain in people aged 
over 55 presenting to primary care: Pragmatic 
randomised trial. British Medical Journal. 
2006;333(7576), 995-998. 
What is the effectiveness of 
enhanced pharmacy review and 
community physiotherapy for 
knee pain? 
pharmacy review and 
community 
physiotherapy 
 6 
Rabenda V, Burlet N, Belaiche J, Raeman F, Richy F, 
Reginster JY. Determinants of gastro-protective drugs co-
prescription during treatment with nonselective NSAIDs: 
a prospective survey of 2197 patients recruited in 
primary care. Osteoarthritis and Cartilage. 
2006;14(7):625-630. 
What is the effectiveness of 
gastro-protective drugs (GPDs) 
during treatment with 
nonselective NSAIDs? 
drug  7 
Mitchell C, Walker J, Walters S, Morgan AB, Binns T, 
Mathers N. Costs and effectiveness of pre- and post-
operative home physiotherapy for total knee 
replacement: randomized controlled trial. 
J.Eval.Clin.Pract. 2005;11(3):283-292. 
What is the effectiveness of pre- 
and post-operative 
physiotherapy at home for 
unilateral total knee 
replacement (TKR)? 
physiotherapy  5 
Mccarthy C, McCarthy CJ, Mills PM, Pullen R, Richardson 
G, Hawkins N et al. Supplementation of a home-based 
exercise programme with a class-based programme for 
people with osteoarthritis of the knees: A randomised 
controlled trial and health economic analysis. Health 
Technology Assessment. 2004;8(46). 
What is the effectiveness of a 
home-based exercise 
programme with a class-based 
programme for OA? 
home-based exercise 
programme with class-
based programme 
 8 
Page 47 of 50 Rheumatology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Raynauld J-, Torrance GW, Band PA, Goldsmith CH, 
Tugwell P, Walker V, et al. A prospective, randomized, 
pragmatic, health outcomes trial evaluating the 
incorporation of hylan G-F 20 into the treatment 
paradigm for patients with knee osteoarthritis (Part 1 of 
2): clinical results. Osteoarthritis and Cartilage. 
2002;10(7):506-517. 
What is the clinical and cost 
effectiveness of hylan G-F 20 for 
knee OA? 
hylan G-F 20  3 
Thomas K, Muir K, Doherty M, Jones A, O'Reilly S, & 
Bassey E. Home Based Exercise Programme For Knee 
Pain And Knee Osteoarthritis: Randomised Controlled 
Trial. British Medical Journal. 2002;325(7367): 752-755. 
Can home-based exercise 
programme improve outcomes 
in patients with knee pain? 
home-based exercise 
programme 
 7 
Torrance GW, Raynauld JP, Walker V, Goldsmith CH, 
Bellamy N, Band PA, et al. A prospective, randomized, 
pragmatic, health outcomes trial evaluating the 
incorporation of hylan G-F 20 into the treatment 
paradigm for patients with knee osteoarthritis (Part 2 of 
2): economic results. Osteoarthritis and Cartilage. 
2002;10(7):518-527. 
What is the effectiveness of 
viscosupplementation of hylan 
G-F 20 for OA? 
hylan G-F 20  5 
Barlow JH, Turner AP, Wright CC. A randomized 
controlled study of the Arthritis Self-Management 
Programme in the UK. Health Educ.Res. 2000;15(6):665-
680. 
Does Arthritis Self-Management 
Programmes (ASMP) improve 
perceptions of control, health 
behaviours and health status, 
and change the use of health 
care resources? 
arthritis self-
management 
programme 
 10 
van Haselen RA, Fisher PAG. A randomized controlled 
trial comparing topical piroxicam gel with a homeopathic 
gel in osteoarthritis of the knee. Rheumatology. 
2000;39(7):714. 
What is the effectiveness of a 
homeopathic gel vs an NSAID 
(piroxicam) gel in the treatment 
of osteoarthritis of the knee? 
homeopathic 
piroxicam gel 
 7 
Fagnani F, Bouvenot G, Valat J, Bardin T, Berdah L, 
Lafuma A, et al. Medico-economic analysis of diacerein 
with or without standard therapy in the treatment of 
osteoarthritis. PharmacoEconomics. 1998;13(1 Pt 2):135-
46. 
What is the effectiveness of 
diacerein with or without 
standard therapy in knee and 
hip OA? 
diacerein  6 
 
Page 48 of 50Rheumatology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Supplementary Table 2. Detailed evaluation of pragmatic trials in osteoarthritis research.   
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Experimental Comparison 
First Author Year 
Participant 
eligibility 
criteria Flexibility 
Practitioner 
expertise  Flexibility 
Practitioner 
expertise 
Follow-
up 
intensity 
Primary 
trial 
outcome 
Participant 
compliance 
Practitioner 
adherence 
Analysis 
of 
primary 
outcome 
Explanation 
for Blinding SUM 
Blikman et al. 2016 1 0 1 1 1 0 1 0 1 1 0 7 
Callahan et al. 2016 1 0 0 1 1 1 1 1 1 1 0 8 
Deyle et al. 2016 0 1 0 0 0 0 1 1 0 0 1 4 
Yu et al. 2016 1 0 0 1 0 0 1 1 1 1 0 6 
Beard et al. 2015 0 0 0 0 0 1 1 0 1 1 1 5 
Cuperus et al. 2015 0 0 0 0 0 1 1 1 1 1 1 6 
Eymard et al. 2015 1 0 0 1 0 0 1 1 0 0 0 4 
Kingsbury et al.  2015 0 0 1 0 1 0 0 0 1 1 1 5 
Moonaz et al.  2015 0 0 0 1 1 1 1 0 1 0 0 5 
Teirlinck et al. 2015 0 1 0 1 1 0 1 1 1 1 0 7 
Bevers et al.  2014 1 1 0 0 0 1 0 1 1 1 0 6 
Broderick et al.  2014 0 0 0 1 1 1 1 1 1 1 0 7 
Dobson et al.  2014 0 1 0 0 1 1 1 0 1 1 0 6 
Foster et al.  2014 0 0 0 0 0 1 1 1 1 1 1 6 
Hermann et al.  2014 1 1 0 0 0 1 0 1 1 1 1 7 
Janke et al. 2014 1 0 0 0 0 0 1 0 0 1 0 3 
Kjeken et al. 2014 1 0 0 0 0 1 1 0 0 1 1 5 
Martins et al. 2014 1 1 0 0 0 1 1 1 1 0 0 6 
Rabago et al.  2014 0 1 0 0 0 1 1 1 1 1 0 6 
Beard et al. 2013 0 1 0 0 0 0 1 0 1 1 0 4 
Kim et al. 2013 0 1 0 1 0 0 1 0 1 1 1 6 
Lee et al.  2013 0 0 0 0 1 1 0 1 1 1 1 6 
Salisbury et al.  2013 1 0 0 0 0 1 0 0 0 0 1 3 
Uehleke et al.  2013 1 1 1 1 1 0 1 0 1 1 0 8 
Adams et al.  2012 1 0 0 0 0 1 1 0 0 1 1 5 
Bennell et al.  2012 0 1 0 0 0 1 1 0 1 1 0 5 
Dakin et al.  2012 1 0 1 1 1 1 1 1 1 1 0 9 
Gooch et al. 2012 1 1 0 1 0 1 1 1 1 1 0 8 
Hinman et al.  2012 0 1 0 0 0 1 1 1 1 1 1 7 
Hurley et al.  2012 0 0 0 1 1 0 1 1 1 1 0 6 
Rathleff et al.  2012 1 0 0 1 0 1 0 0 1 1 1 6 
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Breeman et al. 2011 1 1 0 1 0 1 1 1 1 1 0 8 
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al. 2011 0 0 0 0 0 0 0 0 0 1 0 1 
Juhakoski et al. 2011 0 0 0 1 0 1 1 1 1 1 0 6 
Minns Lowe et 
al. 2011 0 1 0 1 0 1 1 0 1 1 1 7 
Cadmus et al. 2010 0 1 0 1 1 1 1 1 1 1 0 8 
Moe et al.  2010 0 1 0 1 0 1 1 0 1 1 1 7 
Riecke et al.  2010 0 0 0 0 0 0 0 0 0 1 0 1 
Gooch et al.  2009 1 0 0 1 1 1 0 1 1 1 1 8 
Harmer et al. 2009 1 1 0 0 0 1 1 1 1 1 1 8 
Jenkinson et al. 2009 0 1 0 0 1 1 1 1 1 1 0 7 
Jessep et al.  2009 0 1 0 0 0 1 1 1 1 1 0 6 
Lansdown et al.  2009 0 1 0 1 1 1 1 0 1 1 0 7 
Lin et al.  2009 0 0 0 1 0 1 1 0 1 1 1 6 
Rahmann et al. 2009 1 0 0 0 0 1 1 1 0 1 1 6 
Ravaud et al. 2009 0 1 0 1 0 1 1 0 0 1 1 6 
Itoh et al. 2008 0 0 0 0 0 0 1 1 1 0 1 4 
Brealey et al. 2007 0 1 0 0 0 1 1 0 0 1 0 4 
Brinks et al. 2007 0 0 0 1 1 1 1 1 0 1 0 6 
Hurley et al.  2007 0 1 0 1 1 1 1 1 1 1 1 9 
Rosemann et al.  2007 1 1 0 1 1 1 1 0 1 1 0 8 
Hay et al.  2006 0 1 0 0 0 1 1 1 0 1 1 6 
Rabenda et al.  2006 1 1 1 1 1 1 0 0 1 0 0 7 
Mitchell et al. 2005 0 1 0 0 0 1 1 0 1 1 0 5 
McCarthy et al.  2004 1 1 0 0 0 1 1 1 1 1 1 8 
Raynauld et al. 2002 0 0 0 0 0 1 1 0 1 0 0 3 
Thomas et al. 2002 0 0 0 1 1 1 1 0 1 1 1 7 
Torrance et al.  2002 1 0 0 0 0 1 0 1 1 1 0 5 
Barlow et al.  2000 1 1 1 1 1 1 1 1 1 1 0 10 
van Haselen et 
al. 2000 0 1 0 0 0 1 1 1 1 1 1 7 
Fagnani et al. 1998 1 0 0 1 0 1 1 0 1 1 0 6 
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